CELYAD ONCOLOGY S.A. financial statements, including revenue, expenses, profit, and loss
The total revenue of 1C0 for the last semiannual is 58.00 k EUR, and it's 31.82% higher compared to the previous semiannual. The net income of H2 23 is -4.71 M EUR.